日本語English简体中文 繁體中文

4882 Perseus Proteomics Inc.ペルセウスプロテオミクスTSE Growth / Pharmaceuticals

0 posts

Perseus Proteomics Inc. stock fell on Nov 18: what happened

It closed at ¥110 on Nov 18 (−¥10.0, −8.33%), ranking #16 among the top losers of all stocks on the Tokyo Stock Exchange.

Disclosures around that day

Changes are calculated from the closing prices this site collects daily; limit-up/down is an estimate based on the daily price limit. Please make your own investment decisions.

Perseus Proteomics Inc. (4882) at a glance

Code
4882
Company
Perseus Proteomics Inc.
Local name
ペルセウスプロテオミクス
Market
TSE Growth
Sector
Pharmaceuticals
Share price
¥101 -10.0 (-9.01%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Perseus Proteomics Inc. (4882) Stock Price HistoryNear an all-time low

Perseus Proteomics Inc. closed at ¥101 on Nov 20, 2026, −29.9% over 1 month, −67.1% over 1 year.

2026-11-13 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結) / 営業外収益、営業外費用及び特別損失の計上に関するお知らせ2026-11-20 第三者割当による第31回新株予約権(行使価額修正条項付)の発行及び新株予約権買取…¥147¥101Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥147Oct 21
1-Month Low¥101Nov 20
1-Week Change−19.8%vs Nov 13
1-Month Change−29.9%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥70,139 today (−29.9%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −29.9%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥101−10−9.01%
Nov 19 (Thu)¥111+1+0.91%
Nov 18 (Wed)¥110−10−8.33%
Nov 16 (Mon)¥120−6−4.76%
Nov 13 (Fri)¥126+1+0.80%
Nov 12 (Thu)¥125−3−2.34%
Nov 11 (Wed)¥128+2+1.59%
Nov 10 (Tue)¥126+3+2.44%
Nov 9 (Mon)¥123+5+4.24%
Nov 6 (Fri)¥118−16−11.94%
2026-11-13 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結) / 営業外収益、営業外費用及び特別損失の計上に関するお知らせ2026-11-20 第三者割当による第31回新株予約権(行使価額修正条項付)の発行及び新株予約権買取…¥186¥101Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥186Sep 17
3-Month Low¥101Nov 20
1-Month Change−29.9%vs Oct 20
3-Month Change−31.8%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥68,243 today (−31.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −31.8%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥101−10−9.01%
Nov 19 (Thu)¥111+1+0.91%
Nov 18 (Wed)¥110−10−8.33%
Nov 16 (Mon)¥120−6−4.76%
Nov 13 (Fri)¥126+1+0.80%
Nov 12 (Thu)¥125−3−2.34%
Nov 11 (Wed)¥128+2+1.59%
Nov 10 (Tue)¥126+3+2.44%
Nov 9 (Mon)¥123+5+4.24%
Nov 6 (Fri)¥118−16−11.94%
2026-11-13 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結) / 営業外収益、営業外費用及び特別損失の計上に関するお知らせ2026-11-20 第三者割当による第31回新株予約権(行使価額修正条項付)の発行及び新株予約権買取…¥186¥101May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥186Sep 17
6-Month Low¥101Nov 20
3-Month Change−31.8%vs Aug 20
6-Month Change−40.6%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥59,412 today (−40.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −40.6%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥101−28.9%
Oct 2026¥142−15.0%
Sep 2026¥167+16.0%
Aug 2026¥144−0.7%
Jul 2026¥145−8.8%
Jun 2026¥159+2.6%
May 2026¥155−27.6%
2026-11-13 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結) / 営業外収益、営業外費用及び特別損失の計上に関するお知らせ2026-11-20 第三者割当による第31回新株予約権(行使価額修正条項付)の発行及び新株予約権買取…¥312¥101Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥312Nov 28
52-Week Low¥101Nov 20
Year to Date−54.9%vs Dec 30
From 52-Week High−67.6%Nov 28

If you had invested ¥100,000 1 year ago, it would be worth ¥32,899 today (−67.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved −67.1%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥101−28.9%
Oct 2026¥142−15.0%
Sep 2026¥167+16.0%
Aug 2026¥144−0.7%
Jul 2026¥145−8.8%
Jun 2026¥159+2.6%
May 2026¥155−27.6%
Apr 2026¥214−2.7%
Mar 2026¥220−6.0%
Feb 2026¥234−2.5%
Jan 2026¥240+7.1%
Dec 2025¥224−28.2%
Nov 2025¥312―
¥1,034¥101Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥1,034Mar 17, 2025
3-Year Low¥101Nov 20, 2026
Annualized Return−48.5%
Max Drawdown−90.2%

If you had invested ¥100,000 3 years ago, it would be worth ¥13,667 today (−86.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −86.3%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥101−54.9%
2025¥224―
¥1,034¥101Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥1,034Mar 17, 2025
5-Year Low¥101Nov 20, 2026
Annualized Return−25.9%
Max Drawdown−90.2%

If you had invested ¥100,000 5 years ago, it would be worth ¥22,345 today (−77.7%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved −77.7%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥101−54.9%
2025¥224―
¥1,034¥101Jun 21, 2021Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥1,034Mar 2025
All-Time Low¥101Nov 2026
Total Change−87.5%vs Jun 2021
Annualized Return−31.8%

If you had invested ¥100,000 in Jun 2021, it would be worth ¥12,547 today (−87.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.0%, while this stock moved −87.5%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥101−54.9%
2025¥224−60.1%
2024¥562−9.1%
2023¥618+96.8%
2022¥314−20.9%
2021¥397―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jun 2021). Please check the latest prices before trading.

Perseus Proteomics Inc. (4882) financial indicators

PBR
1.97
Dividend yield
0.00%

See all financial indicators for Perseus Proteomics Inc. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of Perseus Proteomics Inc. (4882)

Business overview

The company is a University of Tokyo–born biotech developing antibody drugs. Based on protein expression and antibody production technology developed at the university's Research Center for Advanced Science and Technology, it researches and develops treatments for cancer and other diseases. Its distinctive approach combines the hybridoma, phage display and single B-cell screening methods to create antibodies that can become medicines meeting medical needs.

Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.

Position within Pharmaceuticals (79 companies)

PBR1.97xAbove the sector median of 1.86x (No. 41 from the lowest)
Market cap¥1.9 bnNo. 78 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥3122025/11/28
52-week low¥10111/20
Current position0.0%Where the low is 0% and the high is 100% (close on 11/20: ¥101)
Year to date-54.9%No. 72 of 77 in the sector (best first)
1 year-67.1%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 losers3 timesLatest: 11/18 (No. 16)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (6).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the Perseus Proteomics Inc. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English